Search results

Articles (6)

Journals (0)

1-6 of 6 results for Clazosentan

Sort by:

Relevance

Select all

Sort by:

Relevance

Retricted accessResearch articleFirst published April, 2026

Stratified assessment of clazosentan efficacy following subarachnoid hemorrhage: A multi-center cohort study

Hiroyuki Sakata, Hiroki Uchida, Atsushi Kanoke [...]

Journal of Cerebral Blood Flow & Metabolism

Retricted accessResearch articleFirst published 2025

Quantitative evaluation of the vasodilatory effect of clazosentan in preventing cerebral vasospasm after subarachnoid hemorrhage

Shotaro Ogawa, Satoshi Koizumi, Motoyuki Umekawa [...]

Interventional Neuroradiology

Free accessResearch articleFirst published February, 2015

MEK1/2 Inhibitor U0126 but Not Endothelin Receptor Antagonist Clazosentan Reduces Upregulation of Cerebrovascular Contractile Receptors and Delayed Cerebral Ischemia,and Improves Outcome after Subarachnoid Hemorrhage in Rats

Gro K Povlsen, Lars Edvinsson

Journal of Cerebral Blood Flow & Metabolism

Free accessResearch articleFirst published August, 2005

In vitro evaluation of the cerebrovascular effects of clazosentan,the first clinically effective endothelin-receptor antagonist for the treatment of cerebral vasospasm after subarachnoid hemorrhage

Hartmut Vatter, Michael Zimmermann, Veronika Tesanovic [...]

Journal of Cerebral Blood Flow & Metabolism

Available accessOtherFirst published June, 2006

Profile of Past and Current Clinical Trials Involving Endothelin Receptor Antagonists: The Novel “-Sentan” Class of Drug

Bruno Battistini, Nathalie Berthiaume, Nicholas F. Kelland [...]

Experimental Biology and Medicine

Retricted accessResearch articleFirst published November, 2014

Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?

Tyree H. Kiser

Hospital Pharmacy

Search results

Articles (6)

Journals (0)

1-6 of 6 results for Clazosentan

Sort by:

Relevance

Select all

Sort by:

Relevance

Retricted accessResearch articleFirst published April, 2026

Stratified assessment of clazosentan efficacy following subarachnoid hemorrhage: A multi-center cohort study

Hiroyuki Sakata, Hiroki Uchida, Atsushi Kanoke [...]

Journal of Cerebral Blood Flow & Metabolism

Retricted accessResearch articleFirst published 2025

Quantitative evaluation of the vasodilatory effect of clazosentan in preventing cerebral vasospasm after subarachnoid hemorrhage

Shotaro Ogawa, Satoshi Koizumi, Motoyuki Umekawa [...]

Interventional Neuroradiology

Free accessResearch articleFirst published February, 2015

MEK1/2 Inhibitor U0126 but Not Endothelin Receptor Antagonist Clazosentan Reduces Upregulation of Cerebrovascular Contractile Receptors and Delayed Cerebral Ischemia,and Improves Outcome after Subarachnoid Hemorrhage in Rats

Gro K Povlsen, Lars Edvinsson

Journal of Cerebral Blood Flow & Metabolism

Free accessResearch articleFirst published August, 2005

In vitro evaluation of the cerebrovascular effects of clazosentan,the first clinically effective endothelin-receptor antagonist for the treatment of cerebral vasospasm after subarachnoid hemorrhage

Hartmut Vatter, Michael Zimmermann, Veronika Tesanovic [...]

Journal of Cerebral Blood Flow & Metabolism

Available accessOtherFirst published June, 2006

Profile of Past and Current Clinical Trials Involving Endothelin Receptor Antagonists: The Novel “-Sentan” Class of Drug

Bruno Battistini, Nathalie Berthiaume, Nicholas F. Kelland [...]

Experimental Biology and Medicine

Retricted accessResearch articleFirst published November, 2014

Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?

Tyree H. Kiser

Hospital Pharmacy